Study: NCT03150810

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Administered by mouth as a capsule twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: TMZ at various doses administered by mouth as a capsule once daily.